Table 2.

Differentially expressed glycoproteins identified in subjects with bladder cancer and noncancera

Unique peptide no.Expression in cancer casesFrequencyb
Protein IDProtein name P (FDR)NoncancerCancerNoncancerCancer
P01009Alpha-1-antitrypsin<0.012020Up0.870.98
P02787Serotransferrin0.042025Up0.620.91
P02790Hemopexin0.021420Up0.810.96
P07602Proactivator polypeptide<0.0176Down0.60.34
P07911Uromodulin0.081916Down0.910.7
P10451Osteopontin0.0644Down0.530.29
P16070CD44 antigen0.0643Down0.960.91
Q16769Glutaminyl peptide cyclotransferase<0.0163Down0.510.2
Q9BY67Cell adhesion molecule 1<0.0154Down0.510.2
  • aSpectral counts of urinary glycoproteins with significantly differential abundance (FDR-value < 0.1).

  • bThe candidate must exist in more than half of the noncancer or cancer samples to qualify as a potential marker.